This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly in the design of enzyme inhibitors. Its structure, featuring trifluoromethyl groups and a cyclobutene-dione core, makes it a valuable scaffold for targeting specific proteins or enzymes involved in disease pathways. Researchers explore its potential as a potent inhibitor for enzymes like proteases or kinases, which play critical roles in conditions such as cancer, inflammation, or infectious diseases. Additionally, the stereochemistry introduced by the (2S)-pyrrolidinylmethyl group enhances its binding affinity and selectivity, making it a promising candidate for further optimization in pharmaceutical research. Its applications also extend to chemical biology, where it can be used as a tool compound to study enzyme mechanisms or cellular processes.